The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 1 - 5 millions dollars are the general things for fund. The important activity for fund was in 2015.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Hedge Fund, startups are often financed by EASME - EU Executive Agency for SMEs, Biomedical Catalyst Fund. The meaningful sponsors for the fund in investment in the same round are Scottish Investment Bank. In the next rounds fund is usually obtained by Scottish Investment Bank, Archangels, Julz.
This organization was formed by Jason Libersky.
Among the various public portfolio startups of the fund, we may underline Calcivis Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Medical Device.
Related Funds
| Fund Name | Location |
| Aris Prime Partner | Central, Central Region, Singapore |
| Chengmei Keji | China, Tianjin, Wuqing |
| Chongqing Mingqizhi Qiye Guanli | China, Chongqing, Chongqing Shi |
| Cubit Investments | Israel, Ramat Gan, Tel Aviv |
| Gaocheng Rongxin | China, Guangdong, Shenzhen |
| Greenland Hong Kong Holdings Limited | China, Shanghai |
| Groupon | Chicago, Illinois, United States |
| GVA | England, London, United Kingdom |
| Investar Venture Fund | - |
| Key Safety Systems | Michigan, Sterling Heights, United States |
| Paine Schwartz Partners | New York, New York, United States |
| Pengfeng Rongcheng Capital | - |
| Reliance Industries | India, Maharashtra, Mumbai |
| Sarava | Iran, Tehran, Tehran County |
| Shanghai Xiangyi Touzi Guanli Youxian Gongsi | China, Shanghai |
| Sudamerik Impact Investment | - |
| Tibet Kunwu Jiuding Investment Management | Chengguan District, China, Lhasa |
| TS Ventures GmbH | - |
| University of Washington | Seattle, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Shorter Finance | $4M | 11 Apr 2022 | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Shorter Finance | $4M | 11 Apr 2022 | - |
